| Serial Number | 98480408 |
| Word Mark | SPROUT SOLUTIONS |
| Filing Date | Tuesday, April 2, 2024 |
| Status | 730 - FIRST EXTENSION - GRANTED |
| Status Date | Tuesday, August 19, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 7, 2025 |
| Goods and Services | Research, development, and consulting services related thereto in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; genetic engineering services, namely, research in the field of genetics; biotechnology research and development; scientific, pharmaceutical, and medical research services relating to in the field of biological treatment and bioproduction; providing scientific research information, namely, the provision of information for relating to research and development of biopharmaceuticals that are manufactured using biological treatment and bioproduction platforms development of new technology for others in the field of biotechnology, biomanufacturing, and pharmaceuticals; new product design services; biotechnology design services relating to for the creation of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; providing scientific research information, namely, the preparation of reports relating to biomanufacturing and manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins |
| NOT AVAILABLE | "SOLUTIONS" |
| Goods and Services | Custom manufacturing of pharmaceuticals, biological preparations, chemical preparations, and reagents for others; biomanufacturing for others, namely, manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; biomanufacturing platforms for others, namely, platforms for manufacturing of gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins using biological organisms in the manufacturing process; consulting services in the field of manufacturing processes for pharmaceuticals, biological preparations, chemical preparations, gene therapies, cell therapies, viral vectors, vaccines, oligonucleotides, and proteins; custom processing and manufacture of vectors, cells and proteins for use in the field of biotechnology, being, biomanufacturing for others |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 2, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, April 2, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NATIONAL RESILIENCE, LLC |
| Party Type | 21 - New Owner After Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | BLUE ASH, OH 45242 |
| Party Name | National Resilience, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | National Resilience, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | La Jolla, CA 92037 |
| Event Date | Event Description |
| Tuesday, April 2, 2024 | NEW APPLICATION ENTERED |
| Tuesday, April 2, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, July 12, 2024 | ASSIGNED TO EXAMINER |
| Thursday, July 25, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, July 25, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, July 25, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, October 24, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 24, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 24, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 13, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 1, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 7, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 7, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 4, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, March 4, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Tuesday, March 4, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Tuesday, March 4, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, August 19, 2025 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, August 19, 2025 | SOU EXTENSION 1 FILED |
| Tuesday, August 19, 2025 | SOU EXTENSION 1 GRANTED |
| Thursday, August 21, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, February 11, 2026 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, February 11, 2026 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, February 11, 2026 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, February 11, 2026 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, February 11, 2026 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |